These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1598741)

  • 21. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract.
    Zincke H; Neves RJ
    Urol Clin North Am; 1984 Nov; 11(4):717-24. PubMed ID: 6506376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors affecting the survival of patients treated by standard nephroureterectomy for transitional cell carcinoma of the upper urinary tract.
    Ataus S; Onal B; Tunc B; Erozenci A; Cekmen A; Kural AR; Oner A
    Int Urol Nephrol; 2006; 38(1):9-13. PubMed ID: 16502046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABO, MNSs and rhesus blood groups in bladder cancer.
    Cartwright RA; Adib R; Appleyard I; Glashan RW; Richards B; Robinson MR; Sunderland E; Barham-Hall D
    Br J Urol; 1983 Aug; 55(4):377-81. PubMed ID: 6411162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
    World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of patients with transitional cell carcinoma of the ureter and renal pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia.
    Dragicevic D; Djokic M; Pekmezovic T; Micic S; Hadzi-Djokic J; Vuksanovic A; Simic T
    BJU Int; 2007 Jun; 99(6):1357-62. PubMed ID: 17346272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of
    Lai CC; Chen TJ; Chan TC; Li WS; He HL
    Future Oncol; 2021 Nov; 17(31):4145-4156. PubMed ID: 34467778
    [No Abstract]   [Full Text] [Related]  

  • 29. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; Rouprêt M; Shariat SF
    Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic nephroureterectomy for upper tract transitional cell carcinoma: comparison of laparoscopic and open surgery.
    Tsujihata M; Nonomura N; Tsujimura A; Yoshimura K; Miyagawa Y; Okuyama A
    Eur Urol; 2006 Feb; 49(2):332-6. PubMed ID: 16387415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma.
    Pieras E; Frontera G; Ruiz X; Vicens A; Ozonas M; Pizá P
    BJU Int; 2010 Nov; 106(9):1319-23. PubMed ID: 20394618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups.
    Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Huguet-Pérez J; Vicente-Rodríguez J
    J Urol; 2000 Oct; 164(4):1183-7. PubMed ID: 10992362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
    Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival.
    Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M
    Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of A,B and H blood group antigens in urothelial carcinoma of the urinary bladder].
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Cesk Patol; 1991 Mar; 27(1-2):13-9. PubMed ID: 1893425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
    Chang IW; Wu WJ; Wang YH; Wu TF; Liang PI; He HL; Yeh BW; Li CF
    Histopathology; 2016 Mar; 68(4):520-32. PubMed ID: 26173071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
    Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
    Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma.
    Dragicevic D; Djokic M; Pekmezovic T; Vuksanovic A; Micic S; Hadzi-Djokic J; Tulic C; Milenkovic D; Pljesa-Ercegovac M; Simic T
    Urol Int; 2009; 82(3):335-40. PubMed ID: 19440024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.